Ligand profile
ZINC261596316
Virtual-screening candidate from ZINC.
Bound to: VK055_1436 — putA bifunctional enzyme and transcriptional regulator PutA transcriptional repressor, Proline dehydrogenase/pyrroline-5-carboxylate dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC261596316- UniProt (similar protein)
P09546- Tanimoto
- 0.571
- Target protein
- VK055_1436
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 57.6
- −1 ≤ LogP ≤ 5 1.50
- MW ≤ 500 Da 225.3
- LogP ≤ 5 1.50
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 57.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(O)[C@H]1CC[C@H](C(=O)N2CCCC2)CC1O=C(O)[C@H]1CC[C@H](C(=O)N2CCCC2)CC1
InChI=1S/C12H19NO3/c14-11(13-7-1-2-8-13)9-3-5-10(6-4-9)12(15)16/h9-10H,1-8H2,(H,15,16)/t9-,10-InChI=1S/C12H19NO3/c14-11(13-7-1-2-8-13)9-3-5-10(6-4-9)12(15)16/h9-10H,1-8H2,(H,15,16)/t9-,10-
YSGMQNYXBXGQIB-MGCOHNPYSA-NYSGMQNYXBXGQIB-MGCOHNPYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Query
- ZPJ
- Homolog
- P09546
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC261596316 →
- ZINC ZINC20 ZINC261596316 →
- UniProt UniProt P09546 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC261596316”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1436.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).